Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone (Q36589482)

15 August 2017

1 reference

title

Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone (English)

1 reference

15 August 2017

0 references

1 reference

1

David W Oslin

1 reference

15 August 2017

Wade H Berrettini

2

1 reference

PubMed ID

16961767

15 August 2017

Charles P O'Brien

series ordinal

3

1 reference

15 August 2017

1 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

11

1 reference

15 August 2017

397-403

1 reference

15 August 2017

3-4

1 reference

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Mu opioid receptor gene variants: lack of association with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Anger regulation style, postoperative pain, and relationship to the A118G mu opioid receptor gene polymorphism: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

A conceptual framework for adaptive preventive interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

A genetic association study of the mu opioid receptor and severe opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Comparison of the proopiomelanocortin and proenkephalin opioid peptide systems in brain regions of the alcohol-preferring C57BL/6 and alcohol-avoiding DBA/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Association of functional opioid receptor genotypes with alcohol dependence in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Pharmacogenomics and addiction to opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Naltrexone dampens ethanol-induced cardiovascular and hypothalamic- pituitary-adrenal axis activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Predicting treatment response to naltrexone: the influence of craving and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Plasma cortisol levels following ethanol in sons of alcoholics and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Naltrexone-induced alterations in human ethanol intoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Uncontrollable events and alcohol drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Naltrexone blocks the post-shock increase of ethanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Effect of naltrexone on alcohol "high" in alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Enhanced expression of the inhibitory protein Gi2 alpha and decreased activity of adenylyl cyclase in lymphocytes of abstinent alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2006.00036.X

10.1111/J.1369-1600.2006.00036.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16961767